|
- IRMS - Nicolae Testemitanu SUMPh
- REVISTE MEDICALE NEINSTITUȚIONALE
- Arta Medica
- Arta Medica 2011
- Arta Medica Vol. 45 No.2, 2011 ediţie specială
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/9007
Title: | Prostamol®Uno în tratamentul pacienţilor cu hiperplazie benignă de prostată (experienţa de 10 ani) |
Other Titles: | Prostamol®Uno in treatment of the patients with benign prostatic hyperplasia (experience of 10 years) |
Authors: | Ceban, Emil Tănase, Adrian Lupaşco, Constantin Galescu, Andrei Botnari, Vasile Rusanovschii, V. |
Issue Date: | 2011 |
Publisher: | Asociaţia chirurgilor “Nicolae Anestiadi” din Republica Moldova |
Citation: | CEBAN, E., TĂNASE, A., LUPAŞCO, C., et al. Prostamol ®Uno în tratamentul pacienţilor cu hiperplazie benignă de prostată (experienţa de 10 ani). In: Arta Medica. 2011, nr. 2(45), pp. 35-38. ISSN 1810-1852. |
Abstract: | Summary. During 10 years, between 2001-2011, 760 patients with BPH were treated with Prostamol®Uno, 320mg, daily. In this trial patients were assessed pre- and post- treatment with International Prostate Symptom Score (IPSS), the Quality of Life (QOL), values of PSA and volume of residual urine appreciated ecographically. The analysis of our data shows decrease in IPSS score, QOL and volume of residual urine with in 53,4 %, 57,5% and 48,7% respectively. Prostamol®Uno is one of election drug in conservative treatment of BPH. |
URI: | http://repository.usmf.md/handle/20.500.12710/9007 |
ISSN: | 1810-1852 |
Appears in Collections: | Arta Medica Vol. 45 No.2, 2011 ediţie specială
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|